{"slideshow_credits": null, "snippet": "The billionaire, whose firm is among the worst-performing hedge funds this year, used an investor conference call to take a swipe at the media.", "abstract": "William A Ackman, founder of Pershing Square Capital Management, defends hedge fund's losses in Valeant Pharmaceuticals in conference call with investors; Valeant shares have dropped over 60 percent in past several months due to its drug price hikes.", "section_name": "Business Day", "print_page": "5", "document_type": "article", "byline": {"person": [{"firstname": "Alexandra", "role": "reported", "lastname": "STEVENSON", "rank": 1, "organization": ""}, {"firstname": "Matthew", "role": "reported", "lastname": "GOLDSTEIN", "rank": 2, "organization": ""}], "original": "By ALEXANDRA STEVENSON and MATTHEW GOLDSTEIN"}, "web_url": "http://www.nytimes.com/2015/11/10/business/dealbook/ackman-defends-pershings-valeant-losses-and-digs-at-snide-coverage.html", "lead_paragraph": "The billionaire, whose firm is among the worst-performing hedge funds this year, used an investor conference call to take a swipe at the media.", "headline": {"main": "Ackman Defends Fund\u2019s Valeant Losses and Digs at \u2018Snide Comments\u2019", "print_headline": "Pershing&#8217;s Founder Defends Valeant Losses and Digs at &#8216;Snide Comments&#8217;"}, "_id": "56410adc38f0d80e74ff9725", "word_count": "1213", "multimedia": [{"height": 126, "url": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-10T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Pershing Square Capital Management", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Hedge Funds", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "News and News Media", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Philidor Rx Services LLC", "is_major": "N", "rank": "7"}, {"name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}